NAFLD
260
44
59
106
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
20 trials with published results (8%)
Research Maturity
106 completed trials (41% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.1%
8 terminated out of 260 trials
93.0%
+6.4% vs benchmark
8%
21 trials in Phase 3/4
19%
20 of 106 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 106 completed trials
Clinical Trials (260)
The Effects of 5-methyltetrahydrofolate Supplementation in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease
GLP-1 RA on Liver OMICS in MASLD
Assessment of Fatty Liver With Thermo-acoustic Device
Reversal of Lipid-Induced Insulin Resistance
Short and Long Term Clinical and Patient-Reported Outcomes Associated With Intragastric Balloon Placement in Patients With Nonalcoholic Fatty Liver Disease
Effect of Obesity on Proton Pump Inhibitors
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
Bicalutamide Therapy in Young Women With NAFLD and PCOS
Digoxin In NASH (CODIN)
Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis
The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology
Effects of Phytosterol Supplementation on Liver Function and Inflammatory Status in Patients With Nonalcoholic Fatty Liver Disease
Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH
The Effects of Glucagon on Hepatic Metabolism
Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.
Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease